[1] Pycroft L, Stein J, Aziz T. Deep brain stimulation: an overview of history, methods, and future developments [J]. Brain Neurosci Adv, 2018, 2:2398212818816017. [2] Lozano AM, Dostrovsky J, Chen R, Ashby P. Deep brain stimulation for Parkinson's disease: disrupting the disruption [J]. Lancet Neurol, 2002, 1:225-231. [3] Ricci A, Rubino E, Serra GP, Wallén-Mackenzie Å. Concerning neuromodulation as treatment of neurological and neuropsychiatric disorder: insights gained from selective targeting of the subthalamic nucleus, para-subthalamic nucleus and zona incerta in rodents[J]. Neuropharmacology, 2024, 256: 110003. [4] Mataix-Cols D. New insights into prediction of OCD treatment response, DBS for treatment resistant schizophrenia and bipolar disorder, consensus for the practical management of depression and pain, and coping behaviours in times of crisis[J]. Span J Psychiatry Ment Health, 2025, 18:1-2. [5] Meyer GM, Hollunder B, Li N, Butenko K, Dembek TA, Hart L, Nombela C, Mosley P, Akram H, Acevedo N, Borron BM, Chou T, Castaño Montoya JP, Strange B, Barcia JA, Tyagi H, Castle DJ, Smith AH, Choi KS, Kopell BH, Mayberg HS, Sheth SA, Goodman WK, Leentjens AFG, Richardson RM, Rossell SL, Bosanac P, Cosgrove GR, Kuhn J, Visser-Vandewalle V, Figee M, Dougherty DD, Siddiqi SH, Zrinzo L, Joyce E, Baldermann JC, Fox MD, Neudorfer C, Horn A. Deep brain stimulation for obsessive-compulsive disorder: optimal stimulation sites[J]. Biol Psychiatry, 2024, 96:101-113. [6] Liu S, Qi Y, Hu S, Wei N, Zhang J, Zhu J, Wu H, Hu H, Yang Y, Wang Y. A habenula neural biomarker simultaneously tracks weekly and daily symptom variations during deep brain stimulation therapy for depression[J]. IEEE J Biomed Health Inform, 2025, 29:7090-7103. [7] Abellaneda-Pérez K, Delgado-Martínez I, Salgado P, Ginés JM, Guardiola R, Vaqué-Alcázar L, Roca-Ventura A, Molist-Puigdomènech R, Manero RM, Viles-Garcia M, Medrano-Martorell S, Bartrés-Faz D, Pascual-Leone A, Pérez-Solà V, Villalba-Martínez G. Structural connectivity modifications following deep brain stimulation of the subcallosal cingulate and nucleus accumbens in severe anorexia nervosa [J]. Acta Neurochir (Wien), 2024, 166:364. [8] Biswas T, Singh GK, Mishra P, Mishra BR, Parmar A. Trends of brain stimulation research in substance use disorder: a review of ClinicalTrials. gov registered trials and their publications[J]. Indian J Psychol Med, 2024.[Epub ahead of print] [9] Puccinelli C, Rowa K, Summerfeldt LJ, McCabe RE. Changes in harm avoidance and incompleteness across group CBT for OCD and their relationship with symptom change[J]. Behav Cogn Psychother, 2024, 52:666-680. [10] Nuttin B, Cosyns P, Demeulemeester H, Gybels J, Meyerson B. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder[J]. Lancet, 1999, 354:1526. [11] Xiong B, Li B, Wen R, Gao Y, Gong F, Li D, Xu Y, Deng H, Xiao L, Yin S, Zhang W, Lozano AM, Wang W. Use of differential stimulation of the nucleus accumbens and anterior limb of the internal capsule to improve outcomes of obsessive-compulsive disorder[J]. J Neurosurg, 2023, 139:1376-1385. [12] Chou T, Kochanowski BJ, Hayden A, Borron BM, Barbeiro MC, Xu J, Kim JW, Zhang X, Bouchard RR, Phan KL, Goodman WK, Dougherty DD. A low-intensity transcranial focused ultrasound parameter exploration study of the ventral capsule/ ventral striatum[J]. Neuromodulation, 2025, 28:146-154. [13] Provenza NR, Rajesh SV, Reyes G, Katlowitz KA, Pugalenthi LS, Bechtold RA, Diab N, Reddy S, Allam AK, Gandhi AD, Kabotyanski KE, Mansourian KA, Bentley JH, Altman JR, Hinduja S, Giridharan N, Banks GP, Hasen M, Shofty B, Heilbronner SR, Cohn JF, Borton DA, Storch EA, Herron JA, Hayden BY, Phillips ML, Goodman WK, Sheth SA. High beta power in the ventrolateral prefrontal cortex indexes human approach behavior: a case study[J]. J Neurosci, 2025, 45: e1321242025. [14] Gadot R, Najera R, Hirani S, Anand A, Storch E, Goodman WK, Shofty B, Sheth SA. Efficacy of deep brain stimulation for treatment-resistant obsessive-compulsive disorder: systematic review and meta-analysis[J]. J Neurol Neurosurg Psychiatry, 2022.[Epub ahead of print] [15] Mallet L, Polosan M, Jaafari N, Baup N, Welter ML, Fontaine D, du Montcel ST, Yelnik J, Chéreau I, Arbus C, Raoul S, Aouizerate B, Damier P, Chabardès S, Czernecki V, Ardouin C, Krebs MO, Bardinet E, Chaynes P, Burbaud P, Cornu P, Derost P, Bougerol T, Bataille B, Mattei V, Dormont D, Devaux B, Vérin M, Houeto JL, Pollak P, Benabid AL, Agid Y, Krack P, Millet B, Pelissolo A; STOC Study Group. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder[J]. N Engl J Med, 2008, 359:2121-2134. [16] Acevedo N, Rossell S, Castle D, Groves C, Cook M, McNeill P, Olver J, Meyer D, Perera T, Bosanac P. Clinical outcomes of deep brain stimulation for obsessive-compulsive disorder: insight as a predictor of symptom changes[J]. Psychiatry Clin Neurosci, 2024, 78:131-141. [17] Xu T, Gao Y, Li B, Jiang J, Guo H, Liu X, Huang H, Cheng Y, Yu H, Hu J, Wu X, Wang W, Wang Z. The efficacy and safety of deep brain stimulation of combined anterior limb of internal capsule and nucleus accumbens (ALIC/NAcc-DBS) for treatment-refractory obsessive-compulsive disorder: protocol of a multicenter, randomized, and double-blinded study[J]. Brain Sci, 2022, 12:933. [18] Cohen SE, Niemeijer MJ, Zantvoord JB, van Wingen GA, Mocking RJT, Denys D. Deep brain stimulation for obsessive-compulsive-disorder: a systematic review and meta-analysis of individual participant outcome data from sham-controlled trials [J]. Mol Psychiatry, 2025, 30:4937-4947. [19] Abdulbaki A, El Masri J, Ghazi M, Kahl KG, Mocking RJT, Salameh P, Schuurman R, Nuttin B, Krauss JK. Efficacy of deep brain stimulation for obsessive-compulsive disorder: umbrella review and updated meta-analysis[J]. Psychiatry Res, 2025, 351:116651. [20] Widge AS. Closed-loop deep brain stimulation for psychiatric disorders[J]. Harv Rev Psychiatry, 2023, 31:162-171. [21] Yirmiya R. The inflammatory underpinning of depression: an historical perspective[J]. Brain Behav Immun, 2024, 122:433-443. [22] Papp M, Cubala WJ, Swiecicki L, Newman-Tancredi A, Willner P. Perspectives for therapy of treatment-resistant depression[J]. Br J Pharmacol, 2022, 179:4181-4200. [23] Kajumba MM, Kakooza-Mwesige A, Nakasujja N, Koltai D, Canli T. Treatment-resistant depression: molecular mechanisms and management[J]. Mol Biomed, 2024, 5:43. [24] Drobisz D, Damborská A. Deep brain stimulation targets for treating depression[J]. Behav Brain Res, 2019, 359:266-273. [25] Gholamali Nezhad F, Tassone VK, Khoo Y, Wu M, Lin Q, Demchenko I, Janssen-Aguilar R, Ceniti AK, Rizvi SJ, Lou W, Giacobbe P, Kennedy SH, Lozano AM, McAndrews MP, Bhat V. Lack of neuropsychological effects following short-term subcallosal cingulate gyrus deep brain stimulation in treatment-resistant depression: a randomised crossover study[J]. BMJ Ment Health, 2025, 28:e301408. [26] Dong J, Dai M, Guo Z, Xu T, Li F, Li J. The targets of deep brain stimulation in the treatment of treatment-resistant depression: a review[J]. Brain Behav, 2025, 15:e70505. [27] Armas-Salazar A, Fernandez-Gutiérrez LM, Jader A, Avecillas-Chasin JM, Aronson JP, Pacheco-Barrios N, Altamirano JM. Ventral capsule/ventral striatum deep brain stimulation versus anterior capsulotomy in treatment-resistant major depression: a systematic review and data analysis[J]. Clin Neurol Neurosurg, 2025, 249:108703. [28] Takahashi K, Noda Y, Hondo N, Shibukawa S, Kamagata K, Wada M, Honda S, Homma S, Tsukazaki A, Tsugawa S, Tobari Y, Moriyama S, Taniguchi K, Koike S, Cassidy C, Mimura M, Uchida H, Nakajima S. Abnormal neuritic microstructures in the anterior limb of internal capsules in treatment-resistant depression: a cross-sectional NODDI study[J]. J Psychiatr Res, 2025, 183:93-99. [29] Cui Z, Jiang C, Hu C, Tian Y, Ling Z, Wang J, Fan T, Hao H, Wang Z, Li L. Safety and precision of frontal trajectory of lateral habenula deep brain stimulation surgery in treatment-resistant depression[J]. Front Neurol, 2023, 14:1113545. [30] Wang T, Dai L, Lai Y, Wang F, Zhang Y, Wang Y, Li D, Zhan S, Bian L, Sun B. Parameter-based analysis of clinical efficacy of combined bed nucleus of the stria terminalis-nucleus accumbens deep brain stimulation for treatment-resistant depression[J]. J Neurosurg, 2024, 140:1630-1640. [31] Fenoy AJ, Schulz PE, Sanches M, Selvaraj S, Burrows CL, Asir B, Conner CR, Quevedo J, Soares JC. Deep brain stimulation of the "medial forebrain bundle": sustained efficacy of antidepressant effect over years[J]. Mol Psychiatry, 2022, 27: 2546-2553. MP, Saxena A, Scaini G, Shin JH, Migut A, [32] Dandekar Giridharan VV, Zhou Y, Barichello T, Soares JC, Quevedo J, Fenoy AJ. Medial forebrain bundle deep brain stimulation reverses anhedonic-like behavior in a chronic model of depression: importance of BDNF and inflammatory cytokines [J]. Mol Neurobiol, 2019, 56:4364-4380. [33] Sadeghzadeh S, Swaminathan A, Bhanot P, Steeman S, Xu A, Shah V, Purger DA, Buch VP. Emerging outlook on personalized neuromodulation for depression: insights from tractography-based targeting[J]. Biol Psychiatry Cogn Neurosci Neuroimaging, 2024, 9:754-764. IL, Koujah D, [34] Patel E, Ramaiah P, Mamaril-Davis JC, Bauer Seideman T, Kelbert J, Nosova K, Bina RW. Outcome differences between males and females undergoing deep brain stimulation for treatment-resistant depression: systematic review and individual patient data meta-analysis[J]. J Affect Disord, 2024, 351:481-488. [35] Himes LM, Mayberg HS, Husain MM, Holtzheimer PE, Lozano AM, Kennedy SH, Gross RE, Kopell BH, Figee M, Slavin KV, Pilitsis JG, Neimat JS, Hamani C, Pouratian N, Giacobbe P, Mogilner AY, Nanduri D, Cheeran BJ, Pathak YJ, Riva-Posse P. Revisiting subcallosal cingulate deep brain stimulation for depression: long-term safety and effectiveness outcomes from a pooled analysis of 172 implanted patients[J]. Brain Stimul, 2025, 18:1632-1640. [36] Runia N, Mol GJJ, Denys DAJP, Ardon H, Beute G, Bot M, de Waardt DA, de Knijff DWW, Mocking RJT, Notten P, Rutten GJM, Schuurman PR, van den Munckhof P, van Laarhoven J, van Wingen GA, Bergfeld IO. Deep brain stimulation improves symptoms across all dimensions in treatment-resistant depression [J]. Neurotherapeutics, 2025, 22:e00623. [37] Alemany C, Puigdemont D, Martín-Blanco A, Rodríguez-Rodríguez R, Aibar-Durán JA, Vicent-Gil M, Álvarez E, Pérez V, Portella MJ, Diego -Adeliño J. Response and safety outcomes in treatment-resistant depression after subcallosal cingulate gyrus deep brain stimulation: long-term follow-up study[J]. J Clin Psychiatry, 2023, 84:22m14622. [38] Marwaha S, Palmer E, Suppes T, Cons E, Young AH, Upthegrove R. Novel and emerging treatments for major depression[J]. Lancet, 2023, 401:141-153. [39] Trapani S, Rubino C. Medical complications of anorexia nervosa [J]. Pediatrics, 2025, 156:e2024070304. [40] Austin A, Anderson AG, Lee J, Vander Steen H, Savard C, Bergmann C, Singh M, Devoe D, Gorrell S, Patten S, Le Grange D, Dimitropoulos G. Efficacy of eating disorder focused family therapy for adolescents with anorexia nervosa: a systematic review and Meta-analysis[J]. Int J Eat Disord, 2025, 58:3-36. [41] Baenas I, Etxandi M, Fernández-Aranda F. Medical complications in anorexia and bulimia nervosa[J]. Med Clin (Barc), 2024, 162:67-72. [42] Brand-Gothelf A, Leor S, Apter A, Fennig S. The impact of comorbid depressive and anxiety disorders on severity of anorexia nervosa in adolescent girls[J]. J Nerv Ment Dis, 2014, 202:759-762. [43] Laćan G, De Salles AA, Gorgulho AA, Krahl SE, Frighetto L, Behnke EJ, Melega WP. Modulation of food intake following deep brain stimulation of the ventromedial hypothalamus in the vervet monkey: laboratory investigation[J]. J Neurosurg, 2008, 108:336-342. [44] Hsu TI, Nguyen A, Gupta N, Godbole N, Perisetla N, Hatter MJ, Beyer RS, Bui NE, Jagan J, Yang C, Gendreau J, Brown NJ, Oh M. Effectiveness of deep brain stimulation in treatment of anorexia nervosa and obesity: a systematic review[J]. World Neurosurg, 2022, 168:179-189. [45] Karaszewska D, Cleintuar P, Oudijn M, Lok A, van Elburg A, Denys D, Mocking R. Efficacy and safety of deep brain stimulation for treatment-refractory anorexia nervosa: a systematic review and meta-analysis[J]. Transl Psychiatry, 2022, 12:333. [46] Shaffer A, Naik A, Bederson M, Arnold PM, Hassaneen W. Efficacy of deep brain stimulation for the treatment of anorexia nervosa: a systematic review and network meta-analysis of patient-level data[J]. Neurosurg Focus, 2023, 54:E5. [47] Walsh BT, Hagan KE, Lockwood C. A systematic review comparing atypical anorexia nervosa and anorexia nervosa[J]. Int J Eat Disord, 2023, 56:798-820. [48] Zengin İspir G, Danışman M, Sezer Katar K. Substance use disorders after natural disasters: a narrative review[J]. J Addict Dis, 2024, 42:578-581. [49] Kadam M, Sinha A, Nimkar S, Matcheswalla Y, De Sousa A. A comparative study of factors associated with relapse in alcohol dependence and opioid dependence[J]. Indian J Psychol Med, 2017, 39:627-633. [50] Sakai JT, Tanabe J, Battula S, Zipperly M, Mikulich-Gilbertson SK, Kern DS, Thompson JA, Ojemann S, Raymond K, Gerecht PD, Foster K, Abosch A. Deep brain stimulation for the treatment of substance use disorders: a promising approach requiring caution[J]. Front Psychiatry, 2024, 15:1435109. [51] Purcell JB, Dark HE, Mrug S, Elliott MN, Emery ST, Schuster MA, Knight DC. Adolescent substance use trajectories are associated with nucleus accumbens functional connectivity[J]. J Psychopharmacol, 2025, 39:667-681. [52] Song H, Yang P, Zhang X, Tao R, Zuo L, Liu W, Fu J, Kong Z, Tang R, Wu S, Pang L, Zhang X. Atypical effective connectivity from the frontal cortex to striatum in alcohol use disorder[J]. Transl Psychiatry, 2024, 14:381. [53] Albrechet-Souza L, Kasten CR, Bertagna NB, Wills TA. Sex-specific negative affect-like behaviour and parabrachial nucleus activation induced by BNST stimulation in adult mice with adolescent alcohol history[J]. Addict Biol, 2024, 29:e13366. [54] Leong SL, Glue P, Manning P, Vanneste S, Lim LJ, Mohan A, De Ridder D. Anterior cingulate cortex implants for alcohol addiction: a feasibility study[J]. Neurotherapeutics, 2020, 17: 1287-1299. [55] Vorspan F, Domenech P, Grabli D, Yelnik J, Delavest M, Dauré C, Bellivier F, Pelissolo A, Belaid H, Baunez C, Karachi C, Mallet L. A single case report of STN-DBS for severe crack-cocaine dependence: double-blind ON vs. SHAM randomized controlled assessment[J]. Front Psychiatry, 2023, 14:1146492. [56] Davidson B, Giacobbe P, George TP, Nestor SM, Rabin JS, Goubran M, Nyman AJ, Baskaran A, Meng Y, Pople CB, Graham SJ, Tam F, Hamani C, Lipsman N. Deep brain stimulation of the nucleus accumbens in the treatment of severe alcohol use disorder: a phase Ⅰ pilot trial[J]. Mol Psychiatry, 2022, 27:3992-4000. [57] Bach P, Luderer M, Müller UJ, Jakobs M, Baldermann JC, Voges J, Kiening K, Lux A, Visser-Vandewalle V; DeBraSTRA Study Group; Bogerts B, Kuhn J, Mann K. Deep brain stimulation of the nucleus accumbens in treatment-resistant alcohol use disorder: a double-blind randomized controlled multi-center trial[J]. Transl Psychiatry, 2023, 13:49. [58] Kuhn J, Möller M, Treppmann JF, Bartsch C, Lenartz D, Gruendler TO, Maarouf M, Brosig A, Barnikol UB, Klosterkötter J, Sturm V. Deep brain stimulation of the nucleus accumbens and its usefulness in severe opioid addiction [J]. Mol Psychiatry, 2014, 19:145-146. [59] Chen L, Li N, Ge S, Lozano AM, Lee DJ, Yang C, Li L, Bai Q, Lu H, Wang J, Wang X, Li J, Jing J, Su M, Wei L, Wang X, Gao G. Long-term results after deep brain stimulation of nucleus accumbens and the anterior limb of the internal capsule for preventing heroin relapse: an open-label pilot study[J]. Brain Stimul, 2019, 12:175-183. [60] Shaheen N, Shaheen A, Sarica C, Singh A, Zanaty M, Johari K, Yang A, Zesiewicz T, Dalm B, Bezchlibnyk Y, Lozano AM, Flouty O. Deep brain stimulation for substance use disorder: a systematic review and meta-analysis[J]. Front Psychiatry, 2023, 14:1231760. [61] Zammit Dimech D, Zammit Dimech AA, Hughes M, Zrinzo L. A systematic review of deep brain stimulation for substance use disorders[J]. Transl Psychiatry, 2024, 14:361. [62] Chakrabarti S. Clozapine resistant schizophrenia: newer avenues of management[J]. World J Psychiatry, 2021, 11:429-448. [63] Dutta RR, Picton B, Brown NJ, Yang C, Lee M, Sung H, Lopez AM, Paff M. Schizophrenia and neurosurgery: systematic review and theories[J]. Neurosurg Focus, 2023, 54:E7. [64] Lu J, Gou N, Zhang S, Zhou J, Wang X. Dysfunctional striatal-temporal connect ivity is associated with a higher risk for violence in patients with schizophrenia[J]. Psychiatry Res, 2025, 348:116488. [65] Dai S, Xu Y, Yang T, Wang F, Jiang Y. Identification and correlation analysis of ferroptosis-related genes in three brain regions of patients with schizophrenia[J]. Actas Esp Psiquiatr, 2024, 52:800-809. [66] Aibar-Durán JÁ, Corripio Collado I, Roldán Bejarano A, Sánchez Nevado R, Aracil Bolanos I, García-Cornet J, Alonso-Solís A, Grasa Bello EM, de Quintana Schmidt C, Muñoz Hernández F, Molet Teixidó J, Rodríguez RR. Long-term outcomes of deep brain stimulation for treatment-resistant schizophrenia: exploring potential targets[J]. J Psychiatr Res, 2023, 163:296-304. [67] Corripio I, Roldán A, Sarró S, McKenna PJ, Alonso-Solís A, Rabella M, Díaz A, Puigdemont D, Pérez-Solà V, Álvarez E, Arévalo A, Padilla PP, Ruiz-Idiago JM, Rodríguez R, Molet J, Pomarol-Clotet E, Portella MJ. Deep brain stimulation in treatment resistant schizophrenia: a pilot randomized cross-over clinical trial[J]. EBioMedicine, 2020, 51:102568. [68] Cascella N, Butala AA, Mills K, Kim MJ, Salimpour Y, Wojtasievicz T, Hwang B, Cullen B, Figee M, Moran L, Lenz F, Sawa A, Schretlen DJ, Anderson W. Deep brain stimulation of the substantia nigra pars reticulata for treatment-resistant schizophrenia: a case report[J]. Biol Psychiatry, 2021, 90:e57-e59. [69] Wang Y, Zhang C, Zhang Y, Gong H, Li J, Jin H, Li D, Liu D, Sun B. Habenula deep brain stimulation for intractable schizophrenia: a pilot study[J]. Neurosurg Focus, 2020, 49:E9. [70] Zhang C, Lai Y, Zhang Y, Xu X, Sun B, Li D. Deep brain stimulation-induced transient effects in the habenula[J]. Front Psychiatry, 2021, 12:674962. |